Interleukin 5, IL6, IL12, IFN-γ, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum
- 3 February 2006
- journal article
- rhinology
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 263 (3) , 282-289
Abstract
Polyps are considered to develop as an end result of an inflammatory process. Cytokines and chemokines in the respiratory mucosa may be a key to polyp pathophysiology. The main objective was to identify IL-5, IL-6, IL-12, RANTES, IFN-γ and Fractalkine in humans on the protein level in nasal polyps and mucosa from the inferior turbinate (IT). Furthermore, the cytokines and chemokines RANTES and Fractalkine were analyzed in plasma. Tissue homogenates and plasma from 13 patients were analyzed by the ELISA technique. All the patients had longstanding nasal/paranasal polyposis. Fractalkine was detected in polyps and IT in two different patients. IL-5 was expressed in polyps and IT. IL-6 was expressed in all patients with a higher level in polyps than IT. IL-12 was present in plasma, polyps and IT, though at an increased level in polyps. RANTES was present at a higher level in plasma than in polyps and IT. IFN-γ was detectable in polyps and IT. Fractalkine is detected in nasal polyps, which is a new observation. The overall results indicate a mixed TH1/TH2 cytokine profile in nasal polyps. RANTES and IL-12 are strongly present in plasma, suggesting an ongoing inflammatory “drive”. IL-6 and IL-12 are up-regulated in polyps versus the IT. Up-regulation of IL-6 may be explained by increased fibroblast activity dependant on an ongoing local inflammation possibly initiated by an infection. IL-5, RANTES and IFN-γ are equally represented in polyps and IT, indicating equilibrium between the nasal polyps and surrounding tissue, and that an up-regulation of cytokines in the polyp indicates a potential for polyp growth.Keywords
This publication has 23 references indexed in Scilit:
- Fractalkine Preferentially Mediates Arrest and Migration of CD16+ MonocytesJournal of Experimental Medicine, 2003
- Nasal polyposis: an updateCurrent Opinion in Allergy and Clinical Immunology, 2003
- Mediators in nasal polyposisCurrent Allergy and Asthma Reports, 2002
- Inducible Cyclooxygenase and Interleukin 6 Gene Expressions in Nasal Polyp FibroblastsJAMA Otolaryngology–Head & Neck Surgery, 2002
- Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNSGlia, 2002
- Total and specific IgE in nasal polyps is related to local eosinophilic inflammationJournal of Allergy and Clinical Immunology, 2001
- GM‐CSF, IL‐5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)Clinical & Experimental Allergy, 1998
- Expression of RANTES by Normal Airway Epithelial Cells after Influenza Virus A InfectionAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Eosinophil Infiltration in Nonallergic Chronic Hyperplastic Sinusitis with Nasal Polyposis (CHS/NP) is Associated with Endothelial VCAM-1 Upregulation and Expression of TNF-αAmerican Journal of Respiratory Cell and Molecular Biology, 1996
- Positive Identification in Situ of mRNA Expression of IL-6, and IL-12, and the Chemotactic Cytokine RANTES in Patients with Chronic Sinusitis and Polypoid Disease Clinical Relevance and Relation to AllergyActa Oto-Laryngologica, 1996